Clinical Trials List
2017-01-01 - 2018-06-30
Phase III
Terminated4
ICD-10Z41.1
Encounter for cosmetic surgery
ICD-9V50.1
Elective surgery for other plastic surgery for unacceptable cosmetic appearance
A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Study to Evaluate the Efficacy and Safety of NEURONOX® vs. BOTOX® in Patients with Moderate to Severe Glabellar Lines
-
Trial Applicant
MEDYTOX TAIWAN INC.
-
Sponsor
Medy-Tox
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 王志信 Division of Plastic Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 許永昌 Division of Plastic Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 陳俊嘉 Division of Plastic Surgery
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 李美青 Division of Dermatology
- Yau-Li Huang Division of Dermatology
- Wen-Hung Chung Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Glabellar line improvement rate at maximum frown
Inclution Criteria
Subjects aged between 18 and 65
Subjects with more than grade 2 (moderate) in the investigator's rating of the severity of glabellar lines at maximum frown
Exclusion Criteria
Subjects with medical conditions who may be greater risk due to the administration of the investigational drugs
Subjects with skin disorders at the injection site
The Estimated Number of Participants
-
Taiwan
136 participants
-
Global
136 participants
